melittin derivative (Zhejiang Huahai Pharmaceutical/Dali University)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug Namemelittin derivative (Zhejiang Huahai Pharmaceutical/Dali University)
Drug Alias NameN/A
ClassificationNatural product/ExtractSmall molecules
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsCerebrovascular Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsCerebrovascular Disorders

Other Information

ATC CodeN/A
Related LinksN/A